Corneal Pachymetry Market Size

Corneal Pachymetry Market Size

Corneal Pachymetry Market size was valued at around USD 420.5 million in 2023 and is expected to reach around USD 680.3 million by 2032 at a CAGR of 5.8% between 2024 and 2032. The projected rise in the prevalence of eye disorders such as glaucoma and diabetic retinopathy is anticipated to be a key driver for the market.

The rising incidence of eye disorders, notably glaucoma, poses a substantial global health challenge, impacting both public health and healthcare systems. Factors such as aging population, ethnicity, lifestyle choices, chronic diseases, and genetic predispositions contribute significantly to the increase in glaucoma cases. Diabetic retinopathy and glaucoma stand as the primary contributors for blindness and vision impairment globally.
 

According to the data reported by Centers for Disease Control and Prevention (CDC), diabetic retinopathy ranks as the foremost cause of severe vision loss and blindness among working-age Americans. In 2021, an estimated 4.1 million Americans affected with retinopathy, with 899,000 facing vision-threatening stages of the condition.

Furthermore, glaucoma stands as a leading cause of irreversible blindness in the U.S. As of 2023, over 3 million Americans were affected by glaucoma with limited treatment and cure available for the disorders. Considering these statistics, the increasing prevalence of such conditions underscores the imperative for early detection of these conditions, driving an increased demand for corneal pachymetry devices.

Corneal pachymetry is a medical procedure used to measure the thickness of the cornea, which is the transparent outermost layer of the eye. This measurement is typically performed using specialized instruments called pachymeters, which utilize either ultrasound or optical principles to determine corneal thickness accurately.